The following GLP-1 drugs have been FDA-approved for controlling blood glucose levels in people with Type 2 diabetes: Byetta (exenatide) Bydureon (exenatide extended-release) Victoza (liraglutide) Trulicity (dulaglutide) Ozempic (semaglutide) Rybelsus (oral semaglutide) Tanzeum (albiglutide) Adlyxin (lixisenatide) Soliqua (insulin glargine/lixisenatide combination) Xultophy (insulin degludec/liraglutide combination) In addition, the FDA has approved Mounjaro, a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, for managing glycemic control in Type 2 diabetes
As semaglutide levels decline, the physiological changes it produced begin to reverse
Changes in body composition Some people taking Ozempic notice changes in how their body looks, often described as Ozempic face , Ozempic butt , or Ozempic body. These terms have become popular on social media and are used to describe sagging skin or a more hollow appearance that can follow rapid weight loss
Adding collagen to your post-workout protein shake helps with joint and muscle recovery
While a blender was necessary for smoothie and soup preparation, there was virtually no cleanup required aside from rinsing the blender a major win in my book
Fat Chance: Beating the Odds Against Sugar, Processed Food, Obesity, and Disease Hallberg, S.J., et al